
Gels, Journal Year: 2023, Volume and Issue: 9(12), P. 933 - 933
Published: Nov. 28, 2023
Corneal disorders and diseases are prevalent in the field of clinical ophthalmology. Fungal keratitis, one major factors leading to visual impairment blindness worldwide, presents significant challenges for traditional topical eye drop treatments. The objective this study was create biocompatible 3D-crosslinked hydrogels drug delivery cornea, intending enhance bioavailability ophthalmic drugs. Firstly, a series flexible porous were synthesized (free-radical polymerization), characterized, evaluated. materials prepared by free-radical polymerization reaction 1-vinyl-2-pyrrolidinone (also known as N-vinylpyrrolidone or NVP) 1,6-hexanediol dimethacrylate (crosslinker) presence polyethylene glycol 1000 (PEG-1000) porogen. After physicochemical characterization these materials, chosen hydrogel demonstrated outstanding cytocompatibility vitro. Subsequently, selected could be loaded with voriconazole, an antifungal medication. procedure adapted realize loading 175 mg voriconazole per ring, which slightly exceeds amount that is instilled into via therapy (a single corresponds approximately 100 voriconazole). voriconazole-loaded rings exhibited stable zero-order release pattern over first two hours, points significantly improved drug. Ex vivo experiments using established porcine model provided confirmation 10-fold increase penetration cornea (after 2 h application 35.8 ± 3.2% original dose retrieved from compares 3.9 1% case therapy). These innovative rods show great potential improving drugs, potentially lead reduced hospitalization durations treatment expenses.
Language: Английский